This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Aripiprazole
ABILIFY, ABILIFY MAINTENA, ABILIFYMAINTENA – Bristol-Myers Squibb Canada Co. (NOC Search)
Patents:
- 2379005: MINT, APOTEX
- 2426921: PHARMASCIENCE, TEVA, ACTAVIS, MINT, APOTEX
- 2429496: APOTEX, TEVA, ACTAVIS, PHARMASCIENCE, MINT
- 2475839: APOTEX
- 2511619: PHARMASCIENCE, TEVA, ACTAVIS, MINT, APOTEX
- 2526562: TEVA, ACTAVIS, PHARMASCIENCE, MINT, APOTEX
- 2688915: TEVA, ACTAVIS, MINT, PHARMASCIENCE, APOTEX
- 2688934: TEVA, ACTAVIS, MINT, PHARMASCIENCE, APOTEX
- 2689051: TEVA, ACTAVIS, PHARMASCIENCE, MINT, APOTEX
- 2689052: APOTEX, MINT, TEVA, ACTAVIS, PHARMASCIENCE
- 2700314: APOTEX, MINT, TEVA, ACTAVIS, PHARMASCIENCE
- 2713466: APOTEX, MINT, TEVA, ACTAVIS, PHARMASCIENCE
APOTEX
- Infringement – T-200-17
- PM(NOC) – A-386-17 – T-1566-16 – T-1567-16 – T-1568-16 – T-1569-16 – T-1570-16 – T-1571-16 – T-1572-16 (2017 FC 1061) – T-1573-16 – T-1575-16 – T-1576-16
MINT
- PM(NOC) – T-1660-17
PHARMASCIENCE
- PM(NOC) – T-1217-16
TEVA, ACTAVIS
- PM(NOC) – T-530-17
Return to the Patented Medicine Litigation page.